Kewaunee Scientific Corp. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics
Kewaunee Scientific Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its valuation. The company exhibits strong financial metrics, including a P/E ratio of 6 and a return on equity of 29.30%, indicating effective management and a competitive position within its industry.
Kewaunee Scientific Corp., a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a valuation adjustment. The company's financial metrics reflect a P/E ratio of 6 and a price-to-book value of 1.85, indicating a distinct market positioning. Additionally, Kewaunee's EV to EBIT stands at 9.67, while its EV to EBITDA is recorded at 7.61, showcasing its operational efficiency.The company has demonstrated a solid return on capital employed (ROCE) of 16.14% and a robust return on equity (ROE) of 29.30%, highlighting its profitability and effective management of shareholder equity.
In comparison to its peers, Kewaunee Scientific Corp. stands out with a more favorable valuation profile. While some competitors are classified as risky, Kewaunee's metrics suggest a stronger financial foundation. Notably, Pro-Dex, Inc. is recognized as very attractive, but Kewaunee's valuation remains competitive within the industry landscape.
Overall, the recent evaluation revision reflects the company's solid financial health amidst a challenging market environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
